Amifostine vs no treatment/placebo
Salivary flow rate · Patients receiving radiotherapy on its own or in addition to chemotherapy to the head and neck region
Amifostine led to higher salivary flow rate (incidence of > 0.1 g saliva/5 min, unstimulated) compared with no treatment/placebo; GRADE not reported.
1 finding from 1 review
- Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy 2017 · Cochrane All outcomes12 months postRTRR 1.45 [1.13, 1.86]1 study · 175 participantsGRADE not reported